Literature DB >> 20007365

Diagnosis of Chikungunya fever in an Indian population by an indirect enzyme-linked immunosorbent assay protocol based on an antigen detection assay: a prospective cohort study.

Rajpal Singh Kashyap1, Shweta H Morey, Sonali S Ramteke, Nitin H Chandak, Manmohan Parida, Poonam S Deshpande, Hemant J Purohit, Girdhar M Taori, Hatim F Daginawala.   

Abstract

A Chikungunya virus (CHIKV) outbreak continues in India. Monitoring of the clinical features of CHIKV infection is an important component of assessing the disease process. Diagnosis is usually made by an immunoglobulin M (IgM)/IgG enzyme-linked immunosorbent assay (ELISA). However, these assays have extremely low sensitivities for the detection of infection in the majority of CHIKV patients during the acute stage of infection (during the 1 to 4 days after infection). In our laboratory, a sensitive ELISA protocol for antigen detection has been developed for the detection of CHIKV infection in the acute stage, and in the present study we assessed the usefulness of this ELISA-based system for the detection of CHIKV infection. We performed a prospective, double-blinded study of 205 Indian patients with suspected CHIKV infection in the Nagpur District. All patients underwent a full clinical assessment, and their serum samples were analyzed for the presence of antigens and of IgM and IgG by an ELISA protocol. In patients with CHIKV infection, the sensitivity of antigen detection was 85%, which was significantly higher (P < 0.001) than that of IgM (17%) or IgG (45%) detection. The sensitivity of IgM (20%) or IgG (25%) detection was significantly lower than that of the antigen assay (95%) for patients with acute infections (i.e., from day 1 to day 5 after infection). Antigen detection not only gives a positive confirmatory result in the early phase of the disease, but it is also useful in the prodromal and subclinical stage and may be useful for field applications for the rapid detection of CHIKV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007365      PMCID: PMC2815524          DOI: 10.1128/CVI.00326-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  16 in total

1.  Serotype-cross-reactive immunoglobulin M responses in dengue virus infections determined by enzyme-linked immunosorbent assay.

Authors:  M Nawa; K I Yamada; T Takasaki; T Akatsuka; I Kurane
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

2.  Genotyping of Chikungunya virus isolates from India during 1963-2000 by reverse transcription-polymerase chain reaction.

Authors:  P Yadav; Y S Shouche; H P Munot; A C Mishra; D T Mourya
Journal:  Acta Virol       Date:  2003       Impact factor: 1.162

3.  [Epidemic of Chikungunya virus in 1999 and 200 in the Democratic Republic of the Congo].

Authors:  J J Muyembe-Tamfum; C N Peyrefitte; R Yogolelo; E Mathina Basisya; D Koyange; E Pukuta; M Mashako; H Tolou; J P Durand
Journal:  Med Trop (Mars)       Date:  2003

4.  Laboratory diagnosis of dengue virus infection by reverse transcriptase polymerase chain reaction (RT-PCR) and IgM-capture enzyme-linked immunosorbent assay (ELISA).

Authors:  K Yamada; M Nawa; T Takasaki; S Yabe; I Kurane
Journal:  Jpn J Infect Dis       Date:  1999-08       Impact factor: 1.362

Review 5.  Chikungunya virus infection.

Authors:  I-C Sam; S AbuBakar
Journal:  Med J Malaysia       Date:  2006-06

6.  Etiology of the 1965 epidemic of febrile illness in Nagpur city, Maharashtra State, India.

Authors:  F M Rodrigues; M R Patankar; K Banerjee; P N Bhatt; M K Goverdhan; K M Pavri; M Vittal
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

7.  Chikungunya and dengue: a case of mistaken identity?

Authors:  D E Carey
Journal:  J Hist Med Allied Sci       Date:  1971-07       Impact factor: 2.088

8.  The 1964 chikungunya epidemic at Vellore, South India, including observations on concurrent dengue.

Authors:  D E Carey; R M Myers; C M DeRanitz; M Jadhav; R Reuben
Journal:  Trans R Soc Trop Med Hyg       Date:  1969       Impact factor: 2.184

9.  Chikungunya infection--an emerging disease in Malaysia.

Authors:  S K Lam; K B Chua; P S Hooi; M A Rahimah; S Kumari; M Tharmaratnam; S K Chuah; D W Smith; I A Sampson
Journal:  Southeast Asian J Trop Med Public Health       Date:  2001-09       Impact factor: 0.267

10.  Epidemic resurgence of Chikungunya virus in democratic Republic of the Congo: identification of a new central African strain.

Authors:  B Pastorino; J J Muyembe-Tamfum; M Bessaud; F Tock; H Tolou; J P Durand; C N Peyrefitte
Journal:  J Med Virol       Date:  2004-10       Impact factor: 2.327

View more
  8 in total

1.  Detection of viral antigen, IgM and IgG antibodies in cerebrospinal fluid of Chikungunya patients with neurological complications.

Authors:  Rajpal S Kashyap; Shweta H Morey; Nitin H Chandak; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Cerebrospinal Fluid Res       Date:  2010-08-13

Review 2.  Recent progress on chikungunya virus research.

Authors:  Wenxi An; Ningning Ge; Yilin Cao; Jin Sun; Xia Jin
Journal:  Virol Sin       Date:  2017-11-28       Impact factor: 4.327

3.  Development of an Immunodiagnostic Test for Screening Human Brucellosis Cases Using the Whole-Cell Antigens of Brucella abortus.

Authors:  Nidhi M Bhartiya; Aliabbas A Husain; Hatim F Daginawala; Lokendra Singh; Rajpal S Kashyap
Journal:  Malays J Med Sci       Date:  2020-12-29

4.  Diagnostic accuracy of serological tests for the diagnosis of Chikungunya virus infection: A systematic review and meta-analysis.

Authors:  Anna Andrew; Tholasi Nadhan Navien; Tzi Shien Yeoh; Marimuthu Citartan; Ernest Mangantig; Magdline S H Sum; Ewe Seng Ch'ng; Thean-Hock Tang
Journal:  PLoS Negl Trop Dis       Date:  2022-02-04

Review 5.  Diagnostic Options and Challenges for Dengue and Chikungunya Viruses.

Authors:  Stacey K Mardekian; Amity L Roberts
Journal:  Biomed Res Int       Date:  2015-10-05       Impact factor: 3.411

6.  Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus.

Authors:  Marcílio Jorge Fumagalli; William Marciel de Souza; Danillo Lucas Alves Espósito; Angélica Silva; Marilia Farignoli Romeiro; Edson Zangiacomi Martinez; Benedito Antônio Lopes da Fonseca; Luiz Tadeu Moraes Figueiredo
Journal:  Virol J       Date:  2018-07-24       Impact factor: 4.099

Review 7.  Cellular and Molecular Immune Response to Chikungunya Virus Infection.

Authors:  Ithallo S B Tanabe; Eloiza L L Tanabe; Elane C Santos; Wanessa V Martins; Isadora M T C Araújo; Maria C A Cavalcante; Ana R V Lima; Niels O S Câmara; Leticia Anderson; Dinar Yunusov; Ênio J Bassi
Journal:  Front Cell Infect Microbiol       Date:  2018-10-10       Impact factor: 5.293

8.  Development of in-house serological methods for diagnosis and surveillance of chikungunya.

Authors:  Saira Saborío Galo; Karla González; Yolanda Téllez; Nadezna García; Leonel Pérez; Lionel Gresh; Eva Harris; Ángel Balmaseda
Journal:  Rev Panam Salud Publica       Date:  2017-08-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.